Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Nov 1.

Published in final edited form as: Retina. 2018 Nov;38(11):2247–2252. doi: 10.1097/IAE.0000000000001869

Table 3.

Multivariate analysis for each outcome.

		RAO		RVO		RAO/RVO combined
		Hazard Ratio (95% CI)	p-value^*	Hazard Ratio (95% CI)	p-value^*	Hazard Ratio (95% CI)	p-value^*
Age		1.06 (1.05-1.07)	*<0.001*	1.07 (1.06-1.08)	*<0.001*	1.07 (1.06-1.08)	*<0.001*
Race	*White*	--	*0.01*	--	0.64	--	*0.045*
	*Black, Hispanic, Asian*^τ	1.36 (0.88-2.11)		1.22 (0.80-1.88)		1.22 (0.91-1.65)
	*Unknown*	1.41 (1.12-1.78)		1.02 (0.77-1.35)		1.23 (1.04-1.346)
DM	*Yes*	0.91 (0.69-1.20)	0.50	1.11 (0.82-1.49)	0.50	1.01 (0.83-1.23)	*0.90*
HTN	*Yes*	1.64 (1.29-2.09)	*<0.001*	1.53 (1.12-2.10)	*0.007*	1.57 (1.31-1.88)	*<0.001*
Testosterone	*Yes*	1.43 (1.12-1.81)	*0.004*	1.03 (0.74-1.42)	0.86	1.14 (0.94-1.38)	0.18

^*

p-value <0.05 considered significant

^τ

combined groups due to low individual numbers

-- comparator group

DM = diabetes mellitus

HTN = hypertension

RAO = retinal artery occlusion

RVO = retinal vein occlusion

CI = confidence interval